News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
AstraZeneca PLC Settles U.S. Pricing Lawsuit for $103 Million
June 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca PLC (AZN.L) has agreed to pay $103 million to settle U.S. litigation involving claims the drugmaker inflated prices for its Zoladex cancer drug and Pulmicort Respules asthma medicine.
Twitter
LinkedIn
Facebook
Email
Print
Legal
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
CDC
CDC Left Leaderless Again After Acting Director Departs HHS
February 16, 2026
·
1 min read
·
Tristan Manalac
Regulatory
HHS Backs Prasad Amid Moderna Flu Shot Blowback
February 12, 2026
·
2 min read
·
Tristan Manalac
Legal
AbbVie Sues HHS, CMS for Including Botox in Drug Price Negotiation Program
February 12, 2026
·
1 min read
·
Tristan Manalac
GLP-1
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
February 9, 2026
·
2 min read
·
Tristan Manalac
